企業プロフィール
Enveric Biosciences 株価・ニュース・カタリスト
- ティッカー:
- ENVB
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.41 USD (-1.40%)
終値
最終更新: 2026年8月24日
8.17M USD
時価総額
株価変動の要因
As of Aug 24, 2026, ENVB closed down 1.40% at $1.41. No new same-company headline was identified in the current news window.
企業概要
事業概要
Enveric Biosciences is a neuroscience company focused on next-generation psychedelic-inspired and other CNS therapies. Its story centers on mental-health biology and the search for differentiated neuropsychiatric treatments.
所在地とセクター分類
Enveric is headquartered in the United States and listed on NASDAQ. It sits in small-cap neuroscience biotechnology.
ビジネスモデルの特徴
The company depends on preclinical and early clinical work, translational validation, and capital support. Investors usually watch platform updates, strategic focus, and the ability to maintain a coherent CNS thesis.
バイオ業界での位置付け
Enveric occupies a speculative neuroscience niche within biotech. It is a high-risk story where early platform proof matters a great deal.
今後のカタリスト
- Enveric’s catalysts are psycho-oncology and CNS-related programs, plus any update that shows the platform can still generate value. The market remains early-stage and data-sensitive.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。